BioNTech SE - American Depositary Shares (NQ:BNTX)

97.64 +0.74 (+0.76%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

73 74 Next >

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age

October 12, 2022

From Pfizer Inc.

Via Business Wire

Is Pfizer Stock Still Worth Buying After the Pandemic?

October 12, 2022

Pharmaceutical giant Pfizer (NYSE: PFE) is literally synonymous with COVID-19 vaccines, and as a result, Pfizer stock continues to beat expectations.

Via MarketBeat

Dear NVAX Stock Fans, Mark Your Calendars for Oct. 11 ↗

October 10, 2022

Shares of NVAX stock are climbing ahead of the World Vaccine Congress Europe 2022, where Novavax will share new vaccine data.

Via InvestorPlace

Pfizer's Executive Says European COVID-19 Vaccine Contract Negotiations Did Not Happen Over Text Message ↗

October 10, 2022

A Pfizer Inc (NYSE: PFE) executive has "categorically" ruled out that the pharma giant's chief executive agreed on the European COVID-19 contract via mobile phone text messages.

Via Benzinga

Pfizer's Partner BioNTech Signs Research Pact With Australia ↗

October 07, 2022

Via Benzinga

Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine ↗

September 14, 2022

Via Benzinga

7 Blue-Chip Stocks That Are Too Cheap to Ignore ↗

October 09, 2022

It's time to pounce on the opportunity to buy high-quality at bargain prices, with these seven cheap blue-chip stocks.

Via InvestorPlace

3 Dirt-Cheap Stocks That Could Soar 48% to 68%, According to Wall Street ↗

October 07, 2022

These stocks could attract both value and growth investors.

Via The Motley Fool

BioNTech and Australia’s State of Victoria Form Strategic Partnership to Establish mRNA Research Center and Manufacturing Facility

October 06, 2022

From BioNTech SE

Via GlobeNewswire

Top Five Weekend Stock Stories - Sunday, Oct. 2nd ↗

October 03, 2022

Catch up on the weekend's top five stories with this must read list.

Via Talk Markets

As Moderna Grapples With Supply Shortage, FDA Gives Nod To Additional Lots of COVID-19 Booster ↗

September 27, 2022

Via Benzinga

7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’ ↗

September 27, 2022

Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over.

Via InvestorPlace

September 26, 2022

Bloomberg

Via Benzinga

Pfizer/BioNTech Seek FDA Emergency Nod For Updated COVID-19 Shot For Kids Under 11 Years ↗

September 26, 2022

Via Benzinga

Pfizer CEO Contracts COVID-19 Infection For Second Time ↗

September 26, 2022

Pfizer Inc's (NYSE: PFE) CEO Albert Bourla said he had tested positive for COVID-19.

Via Benzinga

Moderna Seeks FDA Approval For Updated COVID-19 Shot For Kids, But Scrambles Supply Challenges ↗

September 26, 2022

Last week, Moderna Inc (NASDAQ: MRNA) said it asked the FDA to authorize the use of its updated booster shot in children ages 6 to 17. The company expects to complete a request for the use of the...

Via Benzinga

Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age

September 26, 2022

From Pfizer Inc.

Via Business Wire

Switzerland To Dispose 10M Expired COVID-19 Vaccine Doses From Moderna ↗

September 26, 2022

Via Benzinga

Why Is Novavax (NVAX) Stock Falling Today? ↗

September 22, 2022

Novavax still has cash, but it needs to get approval for another vaccine if NVAX stock is to be worth buying again.

Via InvestorPlace

Nikola, Super Micro Computer And Other Big Losers From Monday ↗

September 20, 2022

U.S. stocks closed higher with the Dow Jones gaining around 197 points on Monday. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Check Out What Whales Are Doing With BNTX ↗

September 19, 2022

Someone with a lot of money to spend has taken a bullish stance on BioNTech (NASDAQ:BNTX). And retail traders should know. We noticed this today when the big position showed up on publicly available...

Via Benzinga

Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today? ↗

September 19, 2022

Vaccine stocks are taking it on the chin following President Joe Biden's comments that the "pandemic is over." What now?

Via InvestorPlace

Why BioNTech, Moderna And Novavax Shares Are Diving ↗

September 19, 2022

BioNTech SE - ADR (NASDAQ: BNTX), Moderna Inc (NASDAQ: MRNA) and Novavax, Inc. (NASDAQ: NVAX) are all trading lower during Mo

Via Benzinga

The Silver Lining For Pfizer, Moderna In This Month's IBD/TIPP Poll ↗

September 15, 2022

The companies recently launched their updated Covid booster shots.

Via Investor's Business Daily

Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary ↗

September 12, 2022

Via Benzinga

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union

September 12, 2022

From Pfizer Inc.

Via Business Wire

Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary ↗

September 09, 2022

Via Benzinga

Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report ↗

September 06, 2022

Via Benzinga

White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox ↗

September 02, 2022

Via Benzinga

Moderna, BioNTech Jump After CDC Green-Lights Updated Covid Boosters ↗

September 02, 2022

These new shots target the BA.4 and BA.5 subvariants of omicron.

Via Investor's Business Daily

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

73 74 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.